Chronopharmacology: New insights and therapeutic implications

Annual Review of Pharmacology and Toxicology

Volumn 54, Issue , 2014, Pages 339-361

  Dallmann, Robert ^a   Brown, Steven A ^a   Gachon, Frédéric ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

Cancer; Chronotherapy; Circadian rhythms; Drug metabolism; Peripheral oscillators; Systems biology

Indexed keywords

NEUROTRANSMITTER;

BRAIN REGION; CELL FUNCTION; CHRONOPHARMACOLOGY; CIRCADIAN RHYTHM; DIGESTION; DRUG METABOLISM; HEART FUNCTION; HEPATOBILIARY SYSTEM; HUMAN; HYPOTHALAMUS; IMMUNOREGULATION; INTESTINE ABSORPTION; INTRACELLULAR SIGNALING; KIDNEY; NEOPLASM; NONHUMAN; PHARMACOKINETICS; PREDICTION; PRIORITY JOURNAL; REVIEW; SYSTEMS BIOLOGY;

ANIMALS; CIRCADIAN CLOCKS; DISEASE MODELS, ANIMAL; DRUG CHRONOTHERAPY; HUMANS; HYPOTHALAMUS; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; SUPRACHIASMATIC NUCLEUS;

EID: 84891884471     PISSN: 03621642     EISSN: 15454304     Source Type: Book Series    
DOI: 10.1146/annurev-pharmtox-011613-135923     Document Type: Review

References (166)

1. Hippocrates, Laurentianus L, Miscomini A, Galen. 1494. Hippocratis medici Sententiarum particula prima[-septima]. Florentiae: Antonius Miscominus ex archetypo Laurentii ... imprimi curauit. 196 pp.
2. Lemmer B. 2009. Discoveries of rhythms in human biological functions: a historical review. Chronobiol. Int. 26:1019-68
3. Kamali F, Fry JR, Bell GD. 1987. Temporal variations in paracetamol absorption and metabolism in man. Xenobiotica 17:635-41
4. Watanabe H, Nakano S, Nagai K, Ogawa N. 1984. Time-dependent absorption of theophylline in man. J. Clin. Pharmacol. 24:509-14
5. Abraham U, Granada AE, Westermark PO, Heine M, Kramer A, Herzel H. 2010. Coupling governs entrainment range of circadian clocks. Mol. Syst. Biol. 6:438
6. Reischl S, Kramer A. 2011. Kinases and phosphatases in the mammalian circadian clock. FEBS Lett. 585:1393-99
7. Brown SA. 2011. Circadian rhythms: A new histone code for clocks? Science 333:1833-34
8. Kowalska E, Ripperger JA, Muheim C, Maier B, Kurihara Y, et al. 2012. Distinct roles of DBHS family members in the circadian transcriptional feedback loop. Mol. Cell. Biol. 32:4585-94
9. O'Neill JS, Reddy AB. 2011. Circadian clocks in human red blood cells. Nature 469:498-503
10. Johnson CH, Mori T, Xu Y. 2008. A cyanobacterial circadian clockwork. Curr. Biol. 18:R816-25
11. Dibner C, Schibler U, Albrecht U. 2010. The mammalian circadian timing system: organization and coordination of central and peripheral clocks. Annu. Rev. Physiol. 72:517-49
12. Yamazaki S, Numano R, Abe M, Hida A, Takahashi R, et al. 2000. Resetting central and peripheral circadian oscillators in transgenic rats. Science 288:682-85
13. Damiola F, Le Minh N, Preitner N, Kornmann B, Fleury-Olela F, Schibler U. 2000. Restricted feeding uncouples circadian oscillators in peripheral tissues from the central pacemaker in the suprachiasmatic nucleus. Genes Dev. 14:2950-61
14. Sellix MT, Evans JA, Leise TL, Castanon-Cervantes O, Hill DD, et al. 2012. Aging differentially affects the re-entrainment response of central and peripheral circadian oscillators. J. Neurosci. 32:16193-202
15. Golombek DA, Casiraghi L, Agostino PV, Paladino N, Duhart J, et al. 2013. The times they're a-changing: effects of circadian desynchronization on physiology and disease. J. Physiol. 107:310-22
16. Castanon-Cervantes O, Wu M, Ehlen JC, Paul K, Gamble KL, et al. 2010. Dysregulation of inflammatory responses by chronic circadian disruption. J. Immunol. 185:5796-805
17. Barclay JL, Husse J, Bode B, Naujokat N, Meyer-Kovac J, et al. 2012. Circadian desynchrony promotes metabolic disruption in a mouse model of shiftwork. PLoS ONE 7:e37150
18. Wulff K, Gatti S, Wettstein JG, Foster RG. 2010. Sleep and circadian rhythm disruption in psychiatric and neurodegenerative disease. Nat. Rev. Neurosci. 11:589-99
19. Savvidis C, Koutsilieris M. 2012. Circadian rhythm disruption in cancer biology. Mol. Med. 18:1249-60
20. Panda S, Antoch MP, Miller BH, Su AI, Schook AB, et al. 2002. Coordinated transcription of key pathways in the mouse by the circadian clock. Cell 109:307-20
21. Storch KF, Lipan O, Leykin I, Viswanathan N, Davis FC, et al. 2002. Extensive and divergent circadian gene expression in liver and heart. Nature 417:78-83
22. Gachon F, Fleury-Olela F, Schaad O, Descombes P, Schibler U. 2006. The circadian PAR-domain basic leucine zipper transcription factors DBP, TEF, and HLF modulate basal and inducible xenobiotic detoxification. Cell Metab. 4:25-36
23. Ukai-Tadenuma M, Yamada RG, Xu H, Ripperger JA, Liu AC, Ueda HR. 2011. Delay in feedback repression by Cryptochrome 1 is required for circadian clock function. Cell 144:268-81
24. Kornmann B, Schaad O, Bujard H, Takahashi JS, Schibler U. 2007. System-driven and oscillatordependent circadian transcription in mice with a conditionally active liver clock. PLoS Biol. 5:e34
25. Gerber A, Esnault C, Aubert G, Treisman R, Pralong F, Schibler U. 2013. Blood-borne circadian signal stimulates daily oscillations in actin dynamics and SRF activity. Cell 152:492-503
26. Surjit M, Ganti KP, Mukherji A, Ye T, Hua G, et al. 2011. Widespread negative response elements mediate direct repression by agonist-liganded glucocorticoid receptor. Cell 145:224-41
27. Reinke H, Saini C, Fleury-Olela F, Dibner C, Benjamin IJ, Schibler U. 2008. Differential display of DNA-binding proteins reveals heat-shock factor 1 as a circadian transcription factor. Genes Dev. 22:331-45
28. Jouffe C, Cretenet G, Symul L, Martin E, Atger F, et al. 2013. The circadian clock coordinates ribosome biogenesis. PLoS Biol. 11:e1001455
29. Padmanabhan K, Robles MS, Westerling T, Weitz CJ. 2012. Feedback regulation of transcriptional termination by the mammalian circadian clock PERIOD complex. Science 337:599-602
30. McGlincy NJ, Valomon A, Chesham JE, Maywood ES, Hastings MH, Ule J. 2012. Regulation of alternative splicing by the circadian clock and food related cues. Genome Biol. 13:R54
31. Koike N, Yoo SH, Huang HC, Kumar V, Lee C, et al. 2012. Transcriptional architecture and chromatin landscape of the core circadian clock in mammals. Science 338:349-54
32. LeMartelot G, Canella D, Symul L, Migliavacca E, Gilardi F, et al. 2012. Genome-wideRNApolymerase II profiles and RNA accumulation reveal kinetics of transcription and associated epigenetic changes during diurnal cycles. PLoS Biol. 10:e1001442
33. Menet JS, Rodriguez J, Abruzzi KC, Rosbash M. 2012. Nascent-Seq reveals novel features of mouse circadian transcriptional regulation. eLife 1:e00011
34. Reddy AB, Karp NA, Maywood ES, Sage EA, Deery M, et al. 2006. Circadian orchestration of the hepatic proteome. Curr. Biol. 16:1107-15
35. O'Neill JS, Maywood ES, Chesham JE, Takahashi JS, Hastings MH. 2008. cAMP-dependent signaling as a core component of the mammalian circadian pacemaker. Science 320:949-53
36. Asher G, Schibler U. 2011. Crosstalk between components of circadian andmetabolic cycles inmammals. Cell Metab. 13:125-37
37. Matsuo T, Yamaguchi S, Mitsui S, Emi A, Shimoda F, Okamura H. 2003. Control mechanism of the circadian clock for timing of cell division in vivo. Science 302:255-59
38. Nagoshi E, Saini C, Bauer C, Laroche T, Naef F, Schibler U. 2004. Circadian gene expression in individual fibroblasts: cell-autonomous and self-sustained oscillators pass time to daughter cells. Cell 119:693-705
39. Sporl F, Korge S, Jurchott K, Wunderskirchner M, Schellenberg K, et al. 2012. Krüppel-like factor 9 is a circadian transcription factor in human epidermis that controls proliferation of keratinocytes. Proc. Natl. Acad. Sci. USA 109:10903-8
40. WAF1/CIP1 expression and hepatocyte proliferation. J. Biol. Chem. 283:4535-42
41. Yang X, Wood PA, Hrushesky WJ. 2010. Mammalian TIMELESS is required for ATM-dependent CHK2 activation and G2/M checkpoint control. J. Biol. Chem. 285:3030-34
42. Kowalska E, Ripperger JA, Hoegger DC, Bruegger P, Buch T, et al. 2013.NONOcouples the circadian clock to the cell cycle. Proc. Natl. Acad. Sci. USA 110:1592-99
43. Sancar A, Lindsey-Boltz LA, Kang TH, Reardon JT, Lee JH, Ozturk N. 2010. Circadian clock control of the cellular response to DNA damage. FEBS Lett. 584:2618-25
44. Ruby NF, Hwang CE, Wessells C, Fernandez F, Zhang P, et al. 2008. Hippocampal-dependent learning requires a functional circadian system. Proc. Natl. Acad. Sci. USA 105:15593-98
45. Spencer S, Falcon E, Kumar J, Krishnan V, Mukherjee S, et al. 2013. Circadian genes Period 1 and Period 2 in the nucleus accumbens regulate anxiety-related behavior. Eur. J. Neurosci. 37:242-50
46. Junker U, Wirz S. 2010. Review article: chronobiology: influence of circadian rhythms on the therapy of severe pain. J. Oncol. Pharm. Pract. 16:81-87
47. Miyamoto H, Nakamaru-Ogiso E, Hamada K, Hensch TK. 2012. Serotonergic integration of circadian clock and ultradian sleep-wake cycles. J. Neurosci. 32:14794-803
48. Paolone G, Lee TM, Sarter M. 2012. Time to pay attention: attentional performance time-stamped prefrontal cholinergic activation, diurnality, and performance. J. Neurosci. 32:12115-28
49. Hut RA, Van der Zee EA. 2011. The cholinergic system, circadian rhythmicity, and timememory. Behav. Brain Res. 221:466-80
50. 2 dopamine receptors. J. Neurosci. 30:14046-58
51. Porkka-Heiskanen T, Alanko L, Kalinchuk A, Stenberg D. 2002. Adenosine and sleep. Sleep Med. Rev. 6:321-32
52. Masino S, Boison D, eds. 2013. Adenosine: A Key Link Between Metabolism and Brain Activity. New York: Springer. 679 pp.
53. Kantor S, Mochizuki T, Janisiewicz AM, Clark E, Nishino S, Scammell TE. 2009. Orexin neurons are necessary for the circadian control of REM sleep. Sleep 32:1127-34
54. Kalsbeek A, Palm IF, La Fleur SE, Scheer FA, Perreau-Lenz S, et al. 2006. SCN outputs and the hypothalamic balance of life. J. Biol. Rhythms 21:458-69
55. Tosini G, Baba K, Hwang CK, Iuvone PM. 2012. Melatonin: an underappreciated player in retinal physiology and pathophysiology. Exp. Eye Res. 103:82-89
56. Dominguez-Rodriguez A, Abreu-Gonzalez P, Sanchez-Sanchez JJ, Kaski JC, Reiter RJ. 2010. Melatonin and circadian biology in human cardiovascular disease. J. Pineal Res. 49:14-22
57. Hardeland R, Cardinali DP, Srinivasan V, Spence DW, Brown GM, Pandi-Perumal SR. 2011. Melatonin-a pleiotropic, orchestrating regulator molecule. Prog. Neurobiol. 93:350-84
58. Reddy AB, Maywood ES, Karp NA, King VM, Inoue Y, et al. 2007. Glucocorticoid signaling synchronizes the liver circadian transcriptome. Hepatology 45:1478-88
59. Konturek PC, Brzozowski T, Konturek SJ. 2011. Gut clock: implication of circadian rhythms in the gastrointestinal tract. J. Physiol. Pharmacol. 62:139-50
60. Marcheva B, Ramsey KM, Buhr ED, Kobayashi Y, Su H, et al. 2010. Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes. Nature 466:627-31
61. Ko ML, Shi L, Tsai JY, Young ME, Neuendorff N, et al. 2011. Cardiac-specific mutation of Clock alters the quantitative measurements of physical activities without changing behavioral circadian rhythms. J. Biol. Rhythms 26:412-22
62. Tsai JY, Kienesberger PC, Pulinilkunnil T, Sailors MH, Durgan DJ, et al. 2010. Direct regulation of myocardial triglyceride metabolism by the cardiomyocyte circadian clock. J. Biol. Chem. 285:2918-29
63. Bray MS, Young ME. 2009. The role of cell-specific circadian clocks in metabolism and disease. Obes. Rev. 10(Suppl. 2):6-13
64. Fortier EE, Rooney J, Dardente H, Hardy MP, Labrecque N, Cermakian N. 2011. Circadian variation of the response of T cells to antigen. J. Immunol. 187:6291-300
65. Keller M, Mazuch J, Abraham U, Eom GD, Herzog ED, et al. 2009. A circadian clock in macrophages controls inflammatory immune responses. Proc. Natl. Acad. Sci. USA 106:21407-12
66. Fujimura A, Ohashi K, Ebihara A. 1992. Daily variations in platelet aggregation and adhesion in healthy subjects. Life Sci. 50:1043-47
67. Kluft C, Jie AF, Rijken DC, Verheijen JH. 1988. Daytime fluctuations in blood of tissue-type plasminogen activator (t-PA) and its fast-acting inhibitor (PAI-1). Thromb. Haemost. 59:329-32
68. Mendez-Ferrer S, Lucas D, Battista M, Frenette PS. 2008. Haematopoietic stem cell release is regulated by circadian oscillations. Nature 452:442-47
69. Scheiermann C, Kunisaki Y, Frenette PS. 2013. Circadian control of the immune system. Nat. Rev. Immunol. 13:190-98
70. Moore JG, Englert E Jr. 1970. Circadian rhythm of gastric acid secretion in man. Nature 226:1261-62
71. Goo RH, Moore JG, Greenberg E, Alazraki NP. 1987. Circadian variation in gastric emptying of meals in humans. Gastroenterology 93:515-18
72. Kumar D, Wingate D, Ruckebusch Y. 1986. Circadian variation in the propagation velocity of the migrating motor complex. Gastroenterology 91:926-30
73. Hoogerwerf WA, Shahinian VB, Cornelissen G, Halberg F, Bostwick J, et al. 2010. Rhythmic changes in colonic motility are regulated by period genes. Am. J. Physiol. Gastrointest. Liver Physiol. 298:G143-50
74. Lemmer B, Nold G. 1991. Circadian changes in estimated hepatic blood flow in healthy subjects. Br. J. Clin. Pharmacol. 32:627-29
75. Xu C, Li CY, Kong AN. 2005. Induction of phase I, II and III drug metabolism/transport by xenobiotics. Arch. Pharm. Res. 28:249-68
76. Furuyama K, Kaneko K, Vargas PD. 2007. Heme as a magnificent molecule with multiple missions: heme determines its own fate and governs cellular homeostasis. Tohoku J. Exp. Med. 213:1-16
77. Pandey AV, Fl ück CE. 2013. NADPH P450 oxidoreductase: structure, function, and pathology of diseases. Pharmacol. Ther. 138:229-54
78. Chai X, Zeng S, Xie W. 2013. Nuclear receptors PXR and CAR: implications for drug metabolism regulation, pharmacogenomics and beyond. Expert Opin. Drug Metab. Toxicol. 9:253-66
79. Guyot E, Chevallier A, Barouki R, Coumoul X. 2012. The AhR twist: ligand-dependent AhR signaling and pharmaco-toxicological implications. Drug Discov. Today 18:479-86
80. Rey G, Cesbron F, Rougemont J, Reinke H, Brunner M, Naef F. 2011. Genome-wide and phasespecific DNA-binding rhythms of BMAL1 control circadian output functions in mouse liver. PLoS Biol. 9:e1000595
81. Gachon F, Fonjallaz P, Damiola F, Gos P, Kodama T, et al. 2004. The loss of circadian PAR bZip transcription factors results in epilepsy. Genes Dev. 18:1397-412
82. Takiguchi T, Tomita M, Matsunaga N, Nakagawa H, Koyanagi S, Ohdo S. 2007. Molecular basis for rhythmic expression of CYP3A4 in serum-shocked HepG2 cells. Pharmacogenet. Genomics 17:1047-56
83. Murakami Y, Higashi Y, Matsunaga N, Koyanagi S, Ohdo S. 2008. Circadian clock-controlled intestinal expression of the multidrug-resistance gene mdr1a in mice. Gastroenterology 135:1636-44.e3
84. Beaver LM, Hooven LA, Butcher SM, Krishnan N, Sherman KA, et al. 2010. Circadian clock regulates response to pesticides in Drosophila via conserved Pdp1 pathway. Toxicol. Sci. 115:513-20
85. Beaver LM, Klichko VI, Chow ES, Kotwica-Rolinska J, Williamson M, et al. 2012. Circadian regulation of glutathione levels and biosynthesis in Drosophila melanogaster. PLoS ONE 7:e50454
86. Kang HS, Angers M, Beak JY, Wu X, Gimble JM, et al. 2007. Gene expression profiling reveals a regulatory role for RORαand RORγin phase I and phase II metabolism. Physiol. Genomics 31:281-94
87. Zhang Y-KJ, Yeager RL, Klaassen CD. 2009. Circadian expression profiles of drug-processing genes and transcription factors in mouse liver. Drug Metab. Dispos. 37:106-15
88. Huang P, Ceccatelli S, Rannug A. 2002. A study on diurnalm RNA expression of CYP1A1, AHR, ARNT, and PER2 in rat pituitary and liver. Environ. Toxicol. Pharmacol. 11:119-26
89. Qu X, Metz RP, Porter WW, Cassone VM, Earnest DJ. 2009. Disruption of period gene expression alters the inductive effects of dioxin on the AhR signaling pathway in the mouse liver. Toxicol. Appl. Pharmacol. 234:370-77
90. Tanimura N, Kusunose N, Matsunaga N, Koyanagi S, Ohdo S. 2011. Aryl hydrocarbon receptormediated Cyp1a1 expression is modulated in aCLOCK-dependent circadian manner. Toxicology 290:203-7
91. Matsunaga N, Nakamura N, Yoneda N, Qin T, Terazono H, et al. 2004. Influence of feeding schedule on 24-h rhythm of hepatotoxicity induced by acetaminophen in mice. J. Pharmacol. Exp. Ther. 311:594-600
92. Matsunaga N, Ikeda M, Takiguchi T, Koyanagi S, Ohdo S. 2008. The molecular mechanism regulating 24-hour rhythm of CYP2E1 expression in the mouse liver. Hepatology 48:240-51
93. Trauner M, Wagner M, Fickert P, Zollner G. 2005. Molecular regulation of hepatobiliary transport systems: clinical implications for understanding and treating cholestasis. J. Clin. Gastroenterol. 39(Suppl. 2):S111-24
94. Nakano A, Tietz PS, LaRusso NF. 1990. Circadian rhythms of biliary protein and lipid excretion in rats. Am. J. Physiol. Gastrointest. Liver Physiol. 258:G653-59
95. Duane WC, Gilberstadt ML, Wiegand DM. 1979. Diurnal rhythms of bile acid production in the rat. Am. J. Physiol. Regul. Integr. Comp. Physiol. 236:R175-79
96. Duane WC, Levitt DG, Mueller SM, Behrens JC. 1983. Regulation of bile acid synthesis in man. Presence of a diurnal rhythm. J. Clin. Investig. 72:1930-36
97. Duez H, van der Veen JN, Duhem C, Pourcet B, Touvier T, et al. 2008. Regulation of bile acid synthesis by the nuclear receptor Rev-erbα. Gastroenterology 135:689-98
98. Le Martelot G, Claudel T, Gatfield D, Schaad O, Kornmann B, et al. 2009. REV-ERBαparticipates in circadian SREBP signaling and bile acid homeostasis. PLoS Biol. 7:e1000181
99. Ma K, Xiao R, Tseng H-T, Shan L, Fu L, Moore DD. 2009. Circadian dysregulation disrupts bile acid homeostasis. PLoS ONE 4:e6843
100. Mesnard-Ricci B, White CA. 1998. Chronokinetics of active biliary ampicillin secretion in rats. Chronobiol. Int. 15:309-21
101. Hishikawa S, Sugimoto K, Kobayashi E, Kumagai Y, Fujimura A. 2003. Dosing-time-dependent variation in biliary excretion of flomoxef in rats. Chronobiol. Int. 20:463-71
102. Hishikawa S, Kobayashi E, Sugimoto K-i, Miyata M, Fujimura A. 2001. Diurnal variation in the biliary excretion of flomoxef in patients with percutaneous transhepatic biliary drainage. Br. J. Clin. Pharmacol. 52:65-68
103. Koopman MG, Koomen GC, Krediet RT, de Moor EA, Hoek FJ, Arisz L. 1989. Circadian rhythm of glomerular filtration rate in normal individuals. Clin. Sci. 77:105-11
104. Doi M, Takahashi Y, Komatsu R, Yamazaki F, Yamada H, et al. 2010. Salt-sensitive hypertension in circadian clock-deficient Cry-null mice involves dysregulated adrenal Hsd3b6. Nat. Med. 16:67-74
105. Buijsen JGM, van Acker BAC, Koomen GCM, Koopman MG, Arisz L. 1994. Circadian rhythm of glomerular filtration rate in patients after kidney transplantation. Nephrol. Dial. Transplant. 9:1330-33
106. Sekine T, Miyazaki H, Endou H. 2006. Molecular physiology of renal organic anion transporters. Am. J. Physiol. Ren. Physiol. 290:F251-61
107. Zuber AM, Centeno G, Pradervand S, Nikolaeva S, Maquelin L, et al. 2009. Molecular clock is involved in predictive circadian adjustment of renal function. Proc. Natl. Acad. Sci. USA 106:16523-28
108. +/H+ exchanger NHE3 in the kidney. Kidney Int. 67:1410-19
109. Lago A, Geffner D, Tembl J, Landete L, Valero C, Baquero M. 1998. Circadian variation in acute ischemic stroke: a hospital-based study. Stroke J. Cereb. Circ. 29:1873-75
110. Millar-Craig MW, Bishop CN, Raftery EB. 1978. Circadian variation of blood-pressure. Lancet 1:795-97
111. White WB, Anders RJ, MacIntyre JM, Black HR, Sica DA, Verapamil Study Group. 1995. Nocturnal dosing of a novel delivery system of verapamil for systemic hypertension. Am. J. Cardiol. 76:375-80
112. COER-Verapamil Study Group, White WB, Mehrotra DV, Black HR, Fakouhi TD. 1997. Effects of controlled-onset extended-release verapamil on nocturnal blood pressure (dippers versus nondippers). Am. J. Cardiol. 80:469-74
113. Hermida RC, Ayala DE, Mojon A, Fernandez JR. 2013. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level-the "normotensive non-dipper" paradox. Chronobiol. Int. 30:87-98
114. Ingelsson E, Bjorklund-Bodegard K, Lind L, Arnlov J, Sundstrom J. 2006. Diurnal blood pressure pattern and risk of congestive heart failure. JAMA 295:2859-66
115. Larson AM, Polson J, Fontana RJ, Davern TJ, Lalani E, et al. 2005. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology 42:1364-72
116. Henderson CJ, Pass GJ, Wolf CR. 2006. The hepatic cytochrome P450 reductase null mouse as a tool to identify a successful candidate entity. Toxicol. Lett. 162:111-17
117. 32P content of cancer of the breast. Cancer 21:193-96
118. Hughes ME, DiTacchio L, Hayes KR, Vollmers C, Pulivarthy S, et al. 2009. Harmonics of circadian gene transcription in mammals. PLoS Genet. 5:e1000442
119. Guichard S, Hennebelle I, Bugat R, Canal P. 1998. Cellular interactions of 5-fluorouracil and the camptothecin analogue CPT-11 (irinotecan) in a human colorectal carcinoma cell line. Biochem. Pharmacol. 55:667-76
120. Iurisci I, Filipski E, Sallam H, Harper F, Guettier C, et al. 2009. Liver circadian clock, a pharmacologic target of cyclin-dependent kinase inhibitor seliciclib. Chronobiol. Int. 26:1169-88
121. Gorbacheva VY, Kondratov RV, Zhang R, Cherukuri S, Gudkov AV, et al. 2005. Circadian sensitivity to the chemotherapeutic agent cyclophosphamide depends on the functional status of the CLOCK/BMAL1 transactivation complex. Proc. Natl. Acad. Sci. USA 102:3407-12
122. Zhang X, Diasio RB. 2007. Regulation of human dihydropyrimidine dehydrogenase: implications in the pharmacogenetics of 5-FU-based chemotherapy. Pharmacogenomics 8:257-65
123. Giacchetti S, Dugué PA, Innominato PF, Bjarnason GA, Focan C, et al. 2012. Sex moderates circadian chemotherapy effects on survival of patients with metastatic colorectal cancer: a meta-analysis. Ann. Oncol. 23:3110-16
124. Innominato PF, Giacchetti S, Bjarnason GA, Focan C, Garufi C, et al. 2012. Prediction of overall survival through circadian rest-activity monitoring during chemotherapy for metastatic colorectal cancer. Int. J. Cancer. 131:2684-92
125. Pizarro A, Hayer K, Lahens NF, Hogenesch JB. 2013. Circa DB: a database of mammalian circadian gene expression profiles. Nucleic Acids Res. 41:D1009-13
126. Eckel-Mahan KL, Patel VR, Mohney RP, Vignola KS, Baldi P, Sassone-Corsi P. 2012. Coordination of the transcriptome and metabolome by the circadian clock. Proc. Natl. Acad. Sci. USA 109:5541-46
127. Shah P, Jogani V, Bagchi T, Misra A. 2006. Role of Caco-2 cell monolayers in prediction of intestinal drug absorption. Biotechnol. Prog. 22:186-98
128. Pardini L, Kaeffer B, Trubuil A, Bourreille A, Galmiche JP. 2005. Human intestinal circadian clock: expression of clock genes in colonocytes lining the crypt. Chronobiol. Int. 22:951-61
129. Raehl CL, Patel AK, Le Roy M. 1985. Drug-induced torsade de pointes. Clin. Pharm. 4:675-90
130. Roden DM. 2004. Drug-induced prolongation of the QT interval. N. Engl. J. Med. 350:1013-22
131. Int. Conf. Harmon. Tech. Requir. Regist. Pharm. Hum. Use (ICH). 2005. The non-clinical evaluation of the potential for delayed ventricular repolarization (QT interval prolongation) by human pharmaceuticals. S7B, Step 4 version, May 12. http://www.ich.org/fileadmin/Public-Web-Site/ICH-Products/Guidelines/Safety/ S7B/Step4/S7B-Guideline.pdf
132. Int. Conf. Harmon. Tech. Requir. Regist. Pharm. Hum. Use (ICH). 2005. Guidance for Industry: E14 clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs. E14, October. http://www.fda.gov/downloads/RegulatoryInformation/Guidances/ucm129357.pdf
133. Chain AS, Krudys KM, Danhof M, Della Pasqua O. 2011. Assessing the probability of drug-induced QTc-interval prolongation during clinical drug development. Clin. Pharmacol. Ther. 90:867-75
134. Fijorek K, Patel N, Klima L, Stolarz-Skrzypek K, Kawecka-Jaszcz K, Polak S. 2013. Age and gender dependent heart rate circadian model development and performance verification on the proarrhythmic drug case study. Theor. Biol. Med. Model. 10:7
135. Watanabe J, Suzuki Y, Fukui N, Ono S, Sugai T, et al. 2012. Increased risk of antipsychotic-related QT prolongation during nighttime: a 24-hour Holter electrocardiogram recording study. J. Clin. Psychopharmacol. 32:18-22
136. Jeyaraj D, Haldar SM, Wan X, McCauley MD, Ripperger JA, et al. 2012. Circadian rhythms govern cardiac repolarization and arrhythmogenesis. Nature 483:96-99
137. Brown SA, Fleury-Olela F, Nagoshi E, Hauser C, Juge C, et al. 2005. The period length of fibroblast circadian gene expression varies widely among human individuals. PLoS Biol. 3:e338
138. Wulff K, Dijk DJ, Middleton B, Foster RG, Joyce EM. 2012. Sleep and circadian rhythm disruption in schizophrenia. Br. J. Psychiatry 200:308-16
139. Deuschle M, Schweiger U, Weber B, Gotthardt U, Korner A, et al. 1997. Diurnal activity and pulsatility of the hypothalamus-pituitary-adrenal system in male depressed patients and healthy controls. J. Clin. Endocrinol. Metab. 82:234-38
140. Koskenvuo M, Hublin C, Partinen M, Heikkila K, Kaprio J. 2007. Heritability of diurnal type: a nationwide study of 8753 adult twin pairs. J. Sleep Res. 16:156-62
141. Allebrandt KV, Amin N, Müller-Myhsok B, Esko T, Teder-Laving M, et al. 2013. A KATP channel gene effect on sleep duration: from genome-wide association studies to function in Drosophila. Mol. Psychiatry 18:122-32
142. Roenneberg T, Kuehnle T, Juda M, Kantermann T, Allebrandt K, et al. 2007. Epidemiology of the human circadian clock. Sleep Med. Rev. 11:429-38
143. Chang AM, Scheer FA, Czeisler CA. 2011. The human circadian system adapts to prior photic history. J. Physiol. 589:1095-102
144. Pagani L, Semenova EA, Moriggi E, Revell VL, Hack LM, et al. 2010. The physiological period length of the human circadian clock in vivo is directly proportional to period in human fibroblasts. PLoS ONE 5:e13376
145. Akashi M, Soma H, Yamamoto T, Tsugitomi A, Yamashita S, et al. 2010. Noninvasive method for assessing the human circadian clock using hair follicle cells. Proc. Natl. Acad. Sci. USA 107:15643-48
146. Lewy AJ, Sack RL. 1989. The dim light melatonin onset as a marker for circadian phase position. Chronobiol. Int. 6:93-102
147. Minami Y, Kasukawa T, Kakazu Y, Iigo M, Sugimoto M, et al. 2009. Measurement of internal body time by blood metabolomics. Proc. Natl. Acad. Sci. USA 106:9890-95
148. Kasukawa T, Sugimoto M, Hida A, Minami Y, Mori M, et al. 2012. Human blood metabolite timetable indicates internal body time. Proc. Natl. Acad. Sci. USA 109:15036-41
149. Ueda HR, Chen W, Minami Y, Honma S, Honma K, et al. 2004. Molecular-timetable methods for detection of body time and rhythm disorders from single-time-point genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 101:11227-32
150. Meng QJ, Maywood ES, Bechtold DA, Lu WQ, Li J, et al. 2010. Entrainment of disrupted circadian behavior through inhibition of casein kinase 1 (CK1) enzymes. Proc. Natl. Acad. Sci. USA 107:15240-45
151. Price MA, Kalderon D. 2002. Proteolysis of the Hedgehog signaling effector Cubitus interruptus requires phosphorylation by Glycogen Synthase Kinase 3 and Casein Kinase 1. Cell 108:823-35
152. Kalra PS, Dube MG, Xu B, Farmerie WG, Kalra SP. 1998. Evidence that dark-phase hyperphagia induced by neurotoxin 6-hydroxydopamine may be due to decreased leptin and increased neuropeptide Y signaling. Physiol. Behav. 63:829-35
153. Gannon RL, Millan MJ. 2005. The selective tachykinin neurokinin 1 (NK1) receptor antagonist, GR 205,171, stereospecifically inhibits light-induced phase advances of hamster circadian activity rhythms. Eur. J. Pharmacol. 527:86-93
154. Kumar N, Solt LA, Conkright JJ, Wang Y, Istrate MA, et al. 2010. The benzenesulfoamide T0901317 [N-(2,2,2-trifluoroethyl)-N-[4-[2,2,2-trifluoro-1- hydroxy-1-(trifluoromethyl)ethyl]phenyl]- benzenesulfonamide] is a novel retinoic acid receptor-related orphan receptor-α/γinverse agonist. Mol. Pharmacol. 77:228-36
155. 1 receptor antagonists CP154,526 and DMP695 inhibit light-induced phase advances of hamster circadian activity rhythms. Brain Res. 1083:96-102
156. Chen Z, Yoo SH, Park YS, Kim KH, Wei S, et al. 2012. Identification of diverse modulators of central and peripheral circadian clocks by high-throughput chemical screening. Proc. Natl. Acad. Sci. USA 109:101-6
157. Hirota T, Lee JW, St John PC, Sawa M, Iwaisako K, et al. 2012. Identification of small molecule activators of cryptochrome. Science 337:1094-97
158. Solt LA, Wang Y, Banerjee S, Hughes T, Kojetin DJ, et al. 2012. Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists. Nature 485:62-68
159. Maury E, Ramsey KM, Bass J. 2010. Circadian rhythms and metabolic syndrome: from experimental genetics to human disease. Circ. Res. 106:447-62
160. Maywood ES, Fraenkel E, McAllister CJ, Wood N, Reddy AB, et al. 2010. Disruption of peripheral circadian timekeeping in a mouse model of Huntington's disease and its restoration by temporally scheduled feeding. J. Neurosci. 30:10199-204
161. Dowling GA, Burr RL, Van Someren EJ, Hubbard EM, Luxenberg JS, et al. 2008. Melatonin and bright-light treatment for rest-activity disruption in institutionalized patients with Alzheimer's disease. J. Am. Geriatr. Soc. 56:239-46
162. Martignoni M, Groothuis GMM, de Kanter R. 2006. Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction. Expert Opin. Drug Metab. Toxicol. 2:875-94
163. Panda S, Antoch MP, Miller BH, Su AI, Schook AB, et al. 2002. Coordinated transcription of key pathways in the mouse by the circadian clock. Cell 109:307-20
164. Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA. 2012. The human circadian metabolome. Proc. Natl. Acad. Sci. USA 109:2625-29
165. Smolensky MH, Scott PH, Harrist RB, Hiatt PH, Wong TK, et al. 1987. Administration-timedependency of the pharmacokinetic behavior and therapeutic effect of a once-a-day theophylline in asthmatic children. Chronobiol. Int. 4(3):435-47
166. Smolensky MH, D'Alonzo GE, Kunkel G, Barnes PJ. 1987. Day-night patterns in bronchial patency and dyspnea: basis for once-daily and unequally divided twice-daily theophylline dosing schedules. Chronobiol. Int. 4(3):303-17